Abstract
Hybrid imaging is beneficial for improved medical diagnosis and therapy planning today. Hybrid imaging describes the prospective correlation of two or more complementary sets of imaging information, such as functional and anatomical image volumes. Correlation can be performed through physically combined imaging modalities, such as PET/CT, SPECT/CT, or PET/MR. Here we present first results from employing fully integrated PET/MR tomography for intensity-modulated radiotherapy (IMRT) treatment planning in patients with meningioma using [68Ga]-DOTATOC as the biomarker of choice. Combined PET/MR offers higher soft tissue contrast and the ability to add functional information to the plain combination of MR-based anatomy and PET-based metabolic and molecular information. Furthermore, fully integrated PET/MR employs novel PET technology that is neither available in PET-only nor PET/CT systems. Despite the current lack of broad clinical evidence, integrated PET/MR may become particularly important and clinically useful for improved, individualized RT therapy planning for brain lesions. In particular, logistical and diagnostic benefits of integrated PET/MR-based treatment planning over treatment planning based on PET/CT data may be expected in meningioma patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- APD:
-
Avalanche photodiode
- CT:
-
Computed tomography
- DCE:
-
Dynamic contrast enhanced
- DOTATOC:
-
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-d-Phe1-Tyr3-octreotide (TOC)
- DWI:
-
Diffusion-weighted imaging
- FDG:
-
[18F]-Fluorodeoxyglucose
- FET:
-
O-(2-[18F]-Fluoroethyl)-l-tyrosine
- GTV:
-
Gross target volume
- IMRT:
-
Intensity-modulated radiation therapy
- MET:
-
Methionine
- MI:
-
Mutual information
- mL:
-
Milliliter
- MRI:
-
Magnetic resonance imaging
- MRS:
-
Magnetic resonance spectroscopy
- OSEM:
-
Ordered-subsets expectation maximization
- p.i.:
-
Post injection
- PET:
-
Positron emission tomography
- PTV:
-
Planning target volume
- RT:
-
Radiation therapy
- SNR:
-
Signal-to-noise ratio
- SPECT:
-
Single-photon emission computed tomography
- TBR:
-
Tumor-to-blood ratio
- TV:
-
Target volume
References
Astner ST, Dobrei-Ciuchendea M, Essler M et al (2008) Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 72(4):1161–1167
Beyer T, Pichler B (2009) A decade of combined imaging: from a PET attached to a CT to a PET inside an MR. Eur J Nucl Med Mol Imaging 36(Suppl 1):S1–S2
Beyer T, Weigert M, Quick HH et al (2008) MR-based attenuation correction for torso-PET/MR imaging: pitfalls in mapping MR to CT data. Eur J Nucl Med Mol Imaging 35(6):1142–1146
Beyer T, Freudenberg LS, Townsend DW et al (2011) The future of hybrid imaging—part 3: combined PET/MR and small animal imaging, other imaging combinations and additional concerns. Insights Imaging 2(3):235–246
Bisdas S, Nägele T, Schlemmer HP et al (2009) Switching on the lights for real-time multimodality tumor neuroimaging: the integrated positron-emission tomography/MR imaging system. AJNR Am J Neuroradiol 31(4):610–614
Boss A, Bisdas S, Kolb A et al (2010) Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT. J Nucl Med 51(8):1198–1205
Brix G, Lechel U, Glatting G et al (2005) Radiation exposure of patients undergoing whole-body dual-modality FDG-PET/CT examinations. J Nucl Med 46(4):608–613
Budinger T (1983) Time-of-flight positron emission tomography: status relative to conventional PET. J Nucl Med 24(1):73–78
Czernin J, Allen-Auerbach M, Schelbert HR (2007) Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med 48(Suppl 1):78S–88S
Debus J, Wuendrich M, Pirzkall A et al (2001) High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term result. J Clin Oncol 19(15):3547–3553
Fallanca F, Giovacchini G, Picchio M et al (2009) Incidental detection by [11C]choline PET/CT of meningiomas in prostate cancer patients. Q J Nucl Med Mol Imaging 53(4):417–421
Gehler B, Paulsen F, Öksüz MÖ et al (2009) [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning. Radiat Oncol 4:56
Grosu AL, Weber WA, Astner ST et al (2006) 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 66(2):339–344
Henze M, Schuhmacher J, Hipp P et al (2001) PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. J Nucl Med 42(7):1053–1056
Henze M, Dimitrakopoulou-Strauss A, Milker-Zabel S et al (2005) Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas. J Nucl Med 46(5):763–769
Hofmann M, Steinke F, Scheel V et al (2008) MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med 49(11):1875–1883
Hofmann M, Pichler B, Schölkopf B et al (2009) Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nucl Med Mol Imaging 36(Suppl 1):S93–S103
Hyun SH, Choi JY, Lee KH et al (2011) Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria. J Nucl Med 52(4):547–550
Kinahan PE, Hasegawa BH, Beyer T (2003) X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. Semin Nucl Med 33(3):166–179
Lee JW, Kang KW, Park SH et al (2009) 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma. Eur J Nucl Med Mol Imaging 36(10):1574–1582
Liu RS, Chang CP, Guo WY et al (2010) 1–11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery. J Nucl Med 51(6):883–891
Milker-Zabel S, Zabel-du Bois A, Henze M et al (2006) Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys 65(1):222–227
Milker-Zabel S, Zabel-du Bois A, Huber P et al (2007) Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys 68(3):858–863
Nestle U, Weber W, Hentschel M, Grosu AL (2009) Biological imaging in radiation therapy: role of positron emission tomography. Phys Med Biol 54(1):R1–R25
Nyuyki F, Plotkin M, Graf R et al (2010) Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas. Eur J Nucl Med Mol Imaging 37(2):310–318
Pichler B, Kolb A, Nägele T et al (2010) PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J Nucl Med 51(3):333–336
Rutten I, Cabay JE, Withofs N et al (2007) PET/CT of skull base meningiomas using 2-18F-fluoro-l-tyrosine: initial report. J Nucl Med 48(5):720–725
Schlemmer HP, Pichler BJ, Schmand M et al (2008) Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 248(3):1028–1035
Schmand M, Burbar Z, Corbeil JL et al (2007) BrainPET: first human tomograph for simultaneous (functional) PET and MR imaging. J Nucl Med 48(6):45P
Schulthess G, Burger C (2010) Integrating imaging modalities: what makes sense from a workflow perspective? Eur J Nucl Med Mol Imaging 37(5):980–990
Thorwarth D, Henke G, Müller AC et al (2011) Simultaneous [68Ga]DOTATOC PET/MR for IMRT treatment planning of meningeoma: first experience. Int J Radiat Oncol Biol Phys 81(1):277–283
Townsend DW (2008) Multimodality imaging of structure and function. Phys Med Biol 53(4):R1–R39
Warburg O (1956) On the origin of cancer cells. Science 123:306–314
Werner MK, Schwenzer NF, Thorwarth D (2011) Hybrid MR/PET imaging: principles, problems and potential for radiotherapy. Der Nuklearmediziner 34:108–113
Zaidi H (2007) Is MR-guided attenuation correction a viable option for dual-modality PET/MR imaging? Radiology 244(3):639–642
Acknowledgments
NS, SW, GH, MR, AK, BP for help with patient management, data acquisition, image analysis and data interpretation. DT is supported by the European Social Fund and the Ministry of Science, Research, and the Arts Baden-Württemberg. This work was supported by the Imaging Science Institute (ISI) Tübingen. Mirada Imaging, UK (w3.mirada-medical.com): Software fusion and image display.
Duality-of-Interest
T.B. is president and founder of Switzerland-based cmi-experts GmbH. The Imaging Science Institute of Tübingen is supported by Siemens Healthcare.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Thorwarth, D., Müller, AC., Pfannenberg, C., Beyer, T. (2013). Combined PET/MR Imaging Using 68Ga-DOTATOC for Radiotherapy Treatment Planning in Meningioma Patients. In: Baum, R., Rösch, F. (eds) Theranostics, Gallium-68, and Other Radionuclides. Recent Results in Cancer Research, vol 194. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27994-2_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-27994-2_23
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-27993-5
Online ISBN: 978-3-642-27994-2
eBook Packages: MedicineMedicine (R0)